Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of August 26, 2026, NTRA trades at $328.97 with a market cap of $47.86B and a P/E ratio of -242.01. NTRA moved +0.38% today. Year to date, NTRA is +43.05%; over the trailing twelve months it is +97.90%. Its 52-week range spans $125.38 to $333.56. Analyst consensus is strong buy with an average price target of $335.29. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NTRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $328.97 |
| Market Cap | $47.86B |
| P/E Ratio | -242.01 |
| EPS | $-1.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $333.56 |
| 52-Week Low | $125.38 |
| Volume | 12.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.71B |
| Net Income | $-192.35M |
| Gross Margin | 0.00% |
21 analysts cover NTRA: 0 strong buy, 19 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $335.29.